Last deal

$30M

Amount

Series B

Stage

11.01.2021

Date

2

all rounds

$58.5M

Total amount

Financing round

General

About Company
Sensei Biotherapeutics is a clinical-stage biotechnology company focused on developing next-generation cancer immunotherapies.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Sensei Bio

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company's ImmunoPhage platform uses bacteriophage to induce a robust, coordinated immune response that targets key components of the immune system for the treatment of cancers of unmet need. Sensei Biotherapeutics is dedicated to understanding and selectively interacting with the tumor microenvironment to alter the relationship between host immune cells and cancer, with the goal of developing highly selective therapeutics that treat tumors as if they were infections. The company's team of scientific leaders in biology, immunology, and oncology, along with its proprietary drug discovery platform, ImmunoPhage, positions it to develop effective therapies that contribute value to patients and society.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
VBL THERAPEUTICS

VBL THERAPEUTICS

VBL Therapeutics is a clinical stage biotech company that develops innovative treatments for cancer and immune-inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Or Yehuda, Israel

total rounds

6

total raised

$58.72M
ImmunoGen

ImmunoGen

ImmunoGen is a clinical-stage biotechnology company that develops antibody-based anticancer therapeutics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Waltham, MA, USA

total rounds

7

total raised

$300.5M
Potenza Therapeutics

Potenza Therapeutics

Potenza Therapeutics is a preclinical-stage biotech company developing oncology programs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Health Care

Location

Cambridge, MA, USA

total rounds

2

total raised

$35M
Imugene

Imugene

Imugene is a clinical stage immuno-oncology company that develops immunotherapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Sydney NSW 2000, Australia

total rounds

3

total raised

$70.19M

Financials

Funding Rounds
2
2

Number of Funding Rounds

$58.5M

Money Raised

Their latest funding was raised on 11.01.2021. Their latest investor H&S Ventures. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Catalio Capital Management

Catalio Capital Management

Catalio Capital Management is a NYC venture capital firm focused on investing in biomedical tech startups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Baltimore, MD, USA

total rounds

1

count Of Investments

60

count Of Exists

1
Apeiron Investment Group

Apeiron Investment Group

Apeiron Investment Group invests in various sectors including finance, technology, and real estate.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Real Estate Investment, Real Estate

Location

Sliema, Malta

count Of Investments

23

count Of Exists

1

H&S Ventures

H&S Ventures LLC is a venture capital firm based in North America that invests in startups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

Corona Del Mar, Newport Beach, CA, USA

count Of Investments

3
Cambrian Biopharma

Cambrian Biopharma

Cambrian Biopharma is a company that develops medicines to improve the period of life spent in good health.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Pharmaceuticals

Location

New York, NY, USA

total rounds

6

total raised

$160M

count Of Investments

7
Co-Investors
Investors
10
4

Number of lead investors

10

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Series A
No
Series A, Series B

H&S Ventures

H&S Ventures LLC is a venture capital firm based in North America that invests in startups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

Corona Del Mar, Newport Beach, CA, USA

count Of Investments

3
Apeiron Investment Group

Apeiron Investment Group

Apeiron Investment Group invests in various sectors including finance, technology, and real estate.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Real Estate Investment, Real Estate

Location

Sliema, Malta

count Of Investments

23

count Of Exists

1
Christian Angermayer

Christian Angermayer

Christian Angermayer is a serial entrepreneur and investor. With over 20 years in business, Christian has created, co-founded and invested in numerous successful companies across a broad section of sectors. He has raised over EUR 1.5bn for his portfolio companies and has been involved in more than 40 successful IPO- and M&A-transactions either as an entrepreneur, investor or banker/advisor. He is the owner of Apeiron Investment Group, his family office and merchant banking business, which focuses in Germany and Africa on Financial Services (especially fintech), Internet and Technology (from ecommerce to deep tech), Life Sciences, Media, Real Estate and Natural Resources. Apeiron completes deals across the entire lifecycle and balance sheet of a company, from non-listed Seed/Start Up investments to larger scale Restructuring and Special Situations deals (mostly listed). Christian’s family office holds stakes in various asset management companies with – together with his family office assets - in total approx. EUR 1bn assets under management. Christian has been an entrepreneur since the age of 19 when he started his first business. He loves to push boundaries and to constantly discover, learn about and invest into new opportunities. Highlights include: In 2000 Christian co-founded Ribopharma, which merged with US peer Alnylam Pharmaceuticals in 2003 and subsequently went public (ticker symbol ALNY, USD 8bn Market Cap, a leading company for translation of RNAi as a new class of innovative medicines). In 2004, he created JDC Group, Germany´s largest network of independent financial advisors (IFAs) with more than 16,000 IFAs and more than 1.4m retail clients. In 2007, Christian was one of the first international investors to realize that Africa would be one of the most important “megatrends” for the next few decades. Hence, he founded and created the African Banking Holding ADC African Development Corporation, that merged with Bob Diamond’s Atlas Mara in 2014. Today, merging his profound experience at the nexus of traditional financial services and technology, he is one of the most active and significant investors in European fintech companies with a special focus on crypto-currencies and blockchain-related business models. Other cutting-edge areas for investments Christian is currently most excited about are longevity and anti-aging technologies, aerospace technologies and new drugs for mental wellbeing and enhancement. In 2017, Christian has been the exclusive advisor to Chinese conglomerate HNA Group for building up their 9.9% stake in Deutsche Bank. Christian both had originated the investment idea and structured the entire process and transaction. German business magazine BILANZ ranks Christian among the top 10 most important German tech investors (No. 5/10) in their June 2017 issue and among the 1.000 richest Germans (No. 684/1.000) In addition to his entrepreneurial activities, Christian places great value on social, political and societal commitments. He is a Young Global Leader of the World Economic Forum, a member of the Presidential Advisory Council of His Excellency President Paul Kagame of Rwanda, in the Milken Institute Young Leaders Circle and of Atlantik-Brücke. Passionate about the arts and film, Christian has (executive) produced 14 feature films including critically acclaimed movies like FILTH and HECTOR AND THE SEARCH FOR HAPPINESS. Christian was born in Germany and is based in London.

current job

Presight Capital
Presight Capital

count Of Investments

14

count Of Exists

1
Future Ventures

Future Ventures

Future Ventures is a financial services platform that invests in disruptive technology companies.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Venture Capital, Financial Services

Location

San Francisco, CA, USA

count Of Investments

45

People

Founders
1
Hossein Ghanbari
Hossein Ghanbari

Hossein Ghanbari

Hossein Ghanbari is CEO at Panacea Pharmaceuticals.

current job

Sensei Biotherapeutics
Sensei Biotherapeutics

organization founded

2

Hossein Ghanbari

Employee Profiles
12

Patrick Gallagher

Chief Business Officer

Jessie English

Member Board Of Directors

Jean Campbell

Jean Campbell

Vice President of Biologics Discovery

Steven A. Fuller

Steven A. Fuller

Chief Biopharmaceuticals Development Officer

John K. Celebi

John K. Celebi

President and CEO

Marie-Louise Fjällskog

Marie-Louise Fjällskog

Chief Medical Officer

Robert Pierce

Robert Pierce

Chief Scientific Officer

Hossein Ghanbari

Hossein Ghanbari

Co-Founder

Activity

Recent News
1